What is IBS?

Irritable bowel syndrome (IBS) is a chronic condition that affects the gastrointestinal system, causing symptoms like abdominal pain, changes in bowel habits, and discomfort. It’s quite common, impacting around 9-23% of people globally. IBS can significantly reduce the quality of life for those affected, leading to missed workdays, medical tests, and various treatments.

What types of IBS are there?

There are several types of IBS, including IBS with constipation (IBS-C), IBS with diarrhea (IBS-D), mixed IBS (IBS-M), and unclassified IBS. These subtypes are based on the predominant symptoms experienced by individuals.

Treatment for IBS typically involves a multidisciplinary approach. Some people find relief through lifestyle changes such as dietary adjustments, stress management techniques, and regular physical activity. Others may require medications to help manage their symptoms. The choice of treatment depends on each patient’s specific symptoms and needs.

What are the new advancements in understanding the IBS?

Advancements in understanding IBS have shed light on its complex nature. While the exact cause is still unclear, researchers believe it involves various factors such as genetics, gut microbiota, and environmental triggers. The Rome Criteria IV is commonly used for diagnosing IBS, relying on identifying characteristic symptoms rather than specific test results.

Regarding physical activity, some evidence suggests that activities like yoga, treadmill exercise, or support to increase physical activity may improve symptoms in people with IBS. However, the evidence is limited, and more research is needed to draw firm conclusions. Discussions with patients considering physical activity as part of symptom management should address the uncertainty in the evidence to ensure fully informed decisions.

In conclusion, IBS is a common and chronic condition that can significantly impact a person’s life. Treatment options vary, including lifestyle changes, medications, and alternative therapies. Advancements in understanding IBS continue to emerge, offering hope for improved management and quality of life for those affected.


Bonetto S, Fagoonee S, Battaglia E, Grassini M, Saracco GM, Pellicano R. Recent advances in the treatment of irritable bowel syndrome. Pol Arch Intern Med. 2021 Aug 30;131(7-8):709-715. doi: 10.20452/pamw.16067. Epub 2021 Aug 30. PMID: 34463082.

Nunan D, Cai T, Gardener AD, Ordóñez-Mena JM, Roberts NW, Thomas ET, Mahtani KR. Physical activity for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2022 Jun 29;6(6):CD011497. doi: 10.1002/14651858.CD011497.pub2. PMID: 35766861; PMCID: PMC9243367.

Radovanovic-Dinic B, Tesic-Rajkovic S, Grgov S, Petrovic G, Zivkovic V. Irritable bowel syndrome – from etiopathogenesis to therapy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018 Mar;162(1):1-9. doi: 10.5507/bp.2017.057. Epub 2018 Jan 18. PMID: 29358788.

Saha L. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol. 2014 Jun 14;20(22):6759-73. doi: 10.3748/wjg.v20.i22.6759. PMID: 24944467; PMCID: PMC4051916.